Bringing Innovative Medical Technologies to the GCC
Nexopro helps specialized medical-device companies navigate regulatory requirements, establish clinical adoption, and build sustainable commercial presence across Gulf healthcare markets.
Specialized Medical Technologies
We focus on innovative technologies addressing complex clinical needs and specialist applications.
GCC Expertise
Regulatory knowledge, hospital access, and market development experience across Gulf healthcare systems.
Manufacturer Partnerships
We support partners from market entry through regulatory, clinical, tender, and commercial execution.
Specialized Medical Technologies
A focused portfolio of innovative technologies selected for meaningful clinical impact and specialist healthcare applications.
FlexDex
by FlexDex Surgical
Articulated needle driver designed to enhance precision in minimally invasive surgery.
NeuRx DPS
by Synapse Biomedical
Diaphragm pacing technology for Diaphragm Dysfunction in patients with spinal cord injury or Neuromuscular Disease.
TransAeris
by Synapse Biomedical
Technology designed to prevent and treat Ventilator Induced Diaphragm Dysfunction in ICU.
Your GCC Commercialization Partner
We support innovative medical-device companies across the full market-entry journey.
From regulatory access and clinical engagement to tenders, hospital adoption, and commercial growth.
Regulatory & Market Access
Navigate local registration pathways, documentation requirements, and market-entry processes.
Clinical Engagement
Build relationships with specialists, KOLs, and clinical stakeholders who influence adoption.
Commercial Development
Translate market access into sustainable sales execution and regional expansion.
Hospital and Tender Access
Support institutional engagement, procurement pathways, and tender participation.
Built for GCC Healthcare Market
Nexopro combines regional market knowledge, specialist product focus, and direct healthcare engagement across Gulf markets.
Clinical News & Updates
Latest insights from the world of rare disease, medical technology, and GCC healthcare.
-
NeuRx DPS is granted a new FDA approval
NeuRx DPS, the world leading diaphragm pacing device, helping hundreds of pateints move away from mechanical ventilation, has been granted a new approval in the United States. FDA has granted premarket approval (PMA) of the NeuRx® Diaphragm Pacing System (NeuRx DPS®) for use in patients with spinal cord injuries who rely on mechanical ventilation. PMA […]
-
Diaphragm Pacing a part of Ventilation Management for High Spinal Cord Injury
The American College of Surgeons have issued their guidelines for Spine Surgery in March 2022, The guidelines recommends the consideration for Diaphragm pacing or the first time, with a recommendation to consider stimulation of the diaphragm in high SCI patients in order to plan long-term ventilator strategies and determine a patient’s potential to wean from […]
-
TransAeris deemed a Breakthrough Device by FDA
Using the same technology of diaphragm pacing as its predecessor, and the flagship of Synapse Biomedical Inc®. NeuRx DPS, FDA has granted Breakthrough Therapy Device designation to TransAeris®, a temporary percutaneous intramuscular diaphragm stimulator designed to aid in weaning from mechanical ventilation. TransAeris system is a temporary percutaneous intramuscular diaphragm stimulator intended for patients identified […]
-
Diaphragm Pacing in Cardiac Surgery during the Pandemic
Diaphragm Pacing can Enhance Recovery and Weaning from Mechanical Ventilation (MV) in Cardiac Surgery In a press release published on PRNnewswire website, Synapse Biomedical announced today that surgeons at University Hospitals Cleveland Medical Center have improved the prognosis of several cardiac patients using TransAeris DP for the prevention and treatment of Ventilator Induced Diaphragm Dysfunction […]
-
Superman’s doctor gets FDA approval for temporary use of the system used to take Christopher Reeve off ventilator
The FDA approved a temporary version of the diaphragm pacing system using on “Superman” actor Christopher Reeve after his riding accident left him a quadriplegic. “I also like to say, without Christopher Reeve people wouldn’t have heard about this,” said Dr. Raymond Onders, a surgeon at University Hospitals Cleveland Medical System who pioneered the device. […]
-
TransAeris…a novel approach to prevention and treatment of Ventilator Induced Diaphragm Dysfunction
Patients who undergo major chest and abdominal surgeries that are critically ill have a high tendency for suffering from difficulties in breathing, and often they need to be supported with Mechanical Ventilation (MV). MV can be life-saving for these patients, but on the other hand, it can also be harmful to the patient as continued […]
News post coming soon.
News post coming soon.
News post coming soon.